NABI /DE/
424B3, 1996-12-23
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: NORDSON CORP, 5, 1996-12-23
Next: OAKWOOD HOMES CORP, DEF 14A, 1996-12-23



<PAGE>
 
PROSPECTUS SUPPLEMENT                           Filed pursuant to Rule 424(b)(3)
To Prospectus Dated May 3, 1996,                     Registration No. 333-2253
As Supplemented to Date


                                  $80,500,000

                                     NABI

                6 1/2% Convertible Subordinated Notes due 2003

                                      and
              Shares of Common Stock, Par Value $.10 Per Share, 
                       Issuable Upon Conversion Thereof


        This Prospectus Supplement (the "Supplement") relates to the resale by 
Robertson Stephens & Co. LLC ("Robertson Stephens") of up to $230,000 aggregate 
principal amount of 6 1/2% Convertible Subordinated Notes due 2003 (the 
"Notes") of NABI, a Delaware corporation (the "Company"), originally issued in
private placements consummated on February 7 and March 6, 1996 (the "Debt
Offering"), pursuant to NABI's Registration Statement on Form S-3 (No. 333-
2253)(the "Registration Statement"). This Supplement should be read in
conjunction with the Prospectus dated May 3, 1996, as supplemented to date (the
"Prospectus"), to be delivered with this Supplement. All capitalized terms used
but not defined in this Supplement shall have the meanings given them in the
Prospectus.

        Based on information provided to the Company, the aggregate principal 
amount of the Notes that are currently beneficially owned by Robertson Stephens 
is $230,000, all of which may be sold at this time pursuant to the Prospectus as
supplemented hereby.  Robertson Stephens was an initial purchaser of the Notes 
in the Debt Offering, in connection with which Robertson Stephens received 
customary compensation for its services.  Additional information concerning the
Selling Securityholders (including Robertson Stephens) may be set forth from 
time to time in additional supplements to the Prospectus.  The total outstanding
aggregate principal amount of the Notes is $80,500,000.

        The closing price of the Company's Common Stock as reported on the 
Nasdaq National Market on December 18, 1996 was $9.75 per share.

        The Notes will be subordinated to all existing and future Senior 
Indebtedness of the Company.  At October 31, 1996, Senior Indebtedness was 
approximately $6,700,000.  The Indenture contains no limitations on the 
incurrence of additional indebtedness or other liabilities by the Company.

        The Notes are neither listed on a national securities exchange nor 
quoted on an automated quotation system. However, the Notes are eligible for 
trading in the Private Offerings.  Resales and Trading through Automated 
Linkages ("PORTAL") Market.  Notes sold pursuant to the Registration Statements
will no longer be eligible for trading in the PORTAL Market.

        The date of this Prospectus Supplement is December 19, 1996.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission